Gabapentin recalls
The FDA has published 22 recalls involving Gabapentin since 2013. The latest was reported on 29 Oct 2025. The Harvard Drug Group has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls 22 since 2013
Last 12 months 2 reported
Class I 0 0% of total
Ongoing 7 latest 29 Oct 2025
Recalls per month, last 24 months click a bar for that month
Severity split
Class I 0 0% Class II 15 68% Class III 7 32%
Why gabapentin is recalled
Ongoing gabapentin recalls 7 active
Reported Class Recall Company Reason Where 29 Oct 2025 Drug CLASS II Gabapentin Capsules, USP, 100 mg ( blister packs) recalled The Harvard Drug Group Potency & Assay Nationwide 29 Oct 2025 Drug CLASS II Gabapentin Capsules, USP, 100 mg ( blister pack) recalled Gabapentin The Harvard Drug Group Potency & Assay Nationwide 9 Jul 2025 Drug CLASS II Gabapentin Capsules, USP, 100 mg recalled by The Harvard Drug Group Gabapentin The Harvard Drug Group Packaging Defects Nationwide 9 Jul 2025 Drug CLASS II Gabapentin Capsules, USP, 100 mg , blister pack recalled The Harvard Drug Group Packaging Defects Nationwide 16 Apr 2025 Drug CLASS III Gabapentin Capsules, USP 300 mg recalled Gabapentin SUN Pharmaceutical Industries Packaging Defects Nationwide 16 Apr 2025 Drug CLASS III Gabapentin Capsules, USP 400 mg recalled Gabapentin SUN Pharmaceutical Industries Packaging Defects Nationwide
All gabapentin recalls, newest first 22 total
Reported Class Recall Company Reason Where 29 Oct 2025 Drug CLASS II Gabapentin Capsules, USP, 100 mg ( blister packs) recalled The Harvard Drug Group Potency & Assay Nationwide 29 Oct 2025 Drug CLASS II Gabapentin Capsules, USP, 100 mg ( blister pack) recalled Gabapentin The Harvard Drug Group Potency & Assay Nationwide 9 Jul 2025 Drug CLASS II Gabapentin Capsules, USP, 100 mg recalled by The Harvard Drug Group Gabapentin The Harvard Drug Group Packaging Defects Nationwide 9 Jul 2025 Drug CLASS II Gabapentin Capsules, USP, 100 mg , blister pack recalled The Harvard Drug Group Packaging Defects Nationwide 16 Apr 2025 Drug CLASS III Gabapentin Capsules, USP 300 mg recalled Gabapentin SUN Pharmaceutical Industries Packaging Defects Nationwide 16 Apr 2025 Drug CLASS III Gabapentin Capsules, USP 400 mg recalled Gabapentin SUN Pharmaceutical Industries Packaging Defects Nationwide 16 Apr 2025 Drug CLASS II Gabapentin Tablets 600mg recalled by Glenmark Pharmaceuticals Gabapentin Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 14 Aug 2024 Drug CLASS II Gabapentin Tablets, USP, 600 mg recalled by Granules Pharmaceuticals Gabapentin Granules Pharmaceuticals Other Nationwide 17 May 2023 Drug CLASS III Gabapentin Tablets, USP 600 mg recalled by The Harvard Drug Group Gabapentin The Harvard Drug Group Packaging Defects Nationwide 8 Mar 2023 Drug CLASS III Gabapentin Tablets, USP 600 mg recalled by Sciegen Pharmaceuticals Gabapentin Sciegen Pharmaceuticals Other Nationwide 24 Mar 2021 Drug CLASS II Gabapentin Oral Solution, 250 mg/ per unit dose cup recalled by Akorn Akorn Potency & Assay Nationwide 27 May 2020 Drug CLASS III Gabapentin Tablets USP, 600 mg recalled by InvaGen Pharmaceuticals Gabapentin InvaGen Pharmaceuticals Potency & Assay Nationwide 22 Apr 2020 Drug CLASS II Gabapentin Capsules, USP 100mg recalled by Aurobindo Pharma USA Gabapentin Aurobindo Pharma USA Manufacturing (CGMP) Deviations Nationwide 25 Dec 2019 Drug CLASS II Gabapentin Capsules, USP 100 mg recalled by AuroMedics Pharma AuroMedics Pharma Other Nationwide 17 Jan 2018 Drug CLASS II Gabapentin Tablets, USP, 800 mg recalled by Solco Healtcare US Solco Healtcare US Packaging Defects OH 17 Jan 2018 Drug CLASS III Gabapentin Oral Solution, 250 mg/ (50 mg/mL) in a amber-colored recalled Akorn Manufacturing (CGMP) Deviations Nationwide 14 Jan 2015 Drug CLASS II Gabapentin Capsules, USP 300 mg recalled by Aurobindo Pharma USA Gabapentin Aurobindo Pharma USA Packaging Defects Nationwide 14 Jan 2015 Drug CLASS II Gabapentin Capsules, USP, 100 mg recalled by Actavis Elizabeth Gabapentin Actavis Elizabeth Other PR 14 Jan 2015 Drug CLASS II Gabapentin Capsules, USP, 400 mg recalled by Actavis Elizabeth Gabapentin Actavis Elizabeth Other PR 14 Jan 2015 Drug CLASS II Gabapentin Capsules, USP, 300 mg recalled by Actavis Elizabeth Gaba 300-ezs Actavis Elizabeth Other PR 29 Jan 2014 Drug CLASS II Gabapentin, Tablet, 600 mg recalled by Aidapak Services Aidapak Services Labeling Errors 4 states 22 May 2013 Drug CLASS III Glenmark Gabapentin Tablets, a) 600mg bottle recalled Gabapentin Glenmark Generics Inc. USA Other Nationwide
Should you stop taking Gabapentin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.